Authors' reply to Dr. Malerbi: "Insulin glargine in a Brazilian state: should the government disinvest?"

Appl Health Econ Health Policy. 2014 Oct;12(5):561-3. doi: 10.1007/s40258-014-0113-x.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 1 / drug therapy*
  • Drug Evaluation*
  • Humans
  • Insulin, Isophane / economics*
  • Insulin, Long-Acting / economics*

Substances

  • Insulin, Long-Acting
  • Insulin, Isophane